Objectives: Antiplatelet therapy (APT) promotes bleeding; therefore, APT might worsen outcome
in patients with intracerebral hemorrhage (ICH). We performed a systematic review and …

… with a prior intracerebral hemorrhage compared with … prior intracerebral hemorrhage had
statistically significantly higher rates of MACEs, ischemic stroke, and intracerebral hemorrhage, …

… new intracerebral hemorrhages occurred among statin users with prior intracerebral
hemorrhage and 319 new intracerebral hemorrhages in users with prior ischemic stroke. The risk of …

… intracerebral hemorrhage (ICH); their relative contribution to lobar vs nonlobar hemorrhage
… Prior reports from our group and others support the hypothesis that risk factors for ICH vary …

Non-traumatic intracerebral hemorrhage (ICH) is associated with a significant global burden
of disease, and despite being proportionally less frequent than ischemic stroke, in 2010 it …

… In one of our models, prior antiplatelet use was linked to … between prior antiplatelet use
and hemorrhage growth as … demonstrated a relationship of prior aspirin use with mortality …

… prior statin and aspirin use on clinical outcome following intracerebral hemorrhage (ICH). …
Coagulopathy, seizures on presentation, and prior aspirin use had no significant impact on …

… Recent studies examining the effect of prior antiplatelet therapy (APT) on outcome in
patients with spontaneous intracerebral hemorrhage (ICH) have shown conflicting results. The …

… Large baseline hematoma volume (HV) and hematoma growth (HG) are related to poor
outcome in patients with intracerebral hemorrhage (ICH). It remains controversial whether prior …

… Background and Purpose— There are only limited data on whether prior statin use and/or
cholesterol levels are associated with intracranial hemorrhage (ICH) and outcome after intra-…